Barclays PLC Agenus Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.53 - $0.93 $169,919 - $298,160
-320,603 Reduced 52.56%
289,401 $167,000
Q4 2023

Feb 15, 2024
SELL
$0.63 - $1.14 $184,087 - $333,110
-292,202 Reduced 32.39%
610,004 $505,000
Q3 2023

Nov 07, 2023
BUY
$1.12 - $1.88 $139,628 - $234,375
124,668 Added 16.03%
902,206 $1.02 Million
Q2 2023

Aug 03, 2023
SELL
$1.31 - $2.04 $261,650 - $407,455
-199,733 Reduced 20.44%
777,538 $1.24 Million
Q1 2023

May 04, 2023
BUY
$1.45 - $2.95 $3,469 - $7,059
2,393 Added 0.25%
977,271 $1.49 Million
Q4 2022

Feb 13, 2023
BUY
$2.02 - $3.25 $109,380 - $175,984
54,149 Added 5.88%
974,878 $2.34 Million
Q3 2022

Nov 03, 2022
BUY
$1.96 - $3.14 $1.62 Million - $2.59 Million
824,917 Added 860.97%
920,729 $1.89 Million
Q2 2022

Aug 12, 2022
BUY
$1.3 - $2.64 $34,990 - $71,058
26,916 Added 39.07%
95,812 $186,000
Q1 2022

May 16, 2022
SELL
$2.35 - $3.47 $539,390 - $796,462
-229,528 Reduced 76.91%
68,896 $170,000
Q4 2021

Feb 14, 2022
BUY
$2.92 - $5.74 $500,347 - $983,560
171,352 Added 134.85%
298,424 $960,000
Q3 2021

Nov 09, 2021
SELL
$4.98 - $6.63 $482,830 - $642,805
-96,954 Reduced 43.28%
127,072 $667,000
Q2 2021

Aug 13, 2021
BUY
$2.56 - $5.49 $45,281 - $97,107
17,688 Added 8.57%
224,026 $1.23 Million
Q1 2021

May 13, 2021
BUY
$2.69 - $5.25 $352,992 - $688,926
131,224 Added 174.7%
206,338 $561,000
Q4 2020

Feb 11, 2021
BUY
$3.17 - $4.49 $17,764 - $25,161
5,604 Added 8.06%
75,114 $239,000
Q3 2020

Nov 12, 2020
SELL
$2.98 - $5.2 $28,125 - $49,077
-9,438 Reduced 11.95%
69,510 $277,000
Q2 2020

Aug 12, 2020
BUY
$2.29 - $4.24 $95,174 - $176,218
41,561 Added 111.16%
78,948 $311,000
Q1 2020

May 13, 2020
SELL
$1.92 - $4.39 $135,064 - $308,818
-70,346 Reduced 65.3%
37,387 $91,000
Q4 2019

Feb 10, 2020
BUY
$2.41 - $4.4 $82,609 - $150,823
34,278 Added 46.67%
107,733 $438,000
Q3 2019

Nov 14, 2019
SELL
$2.17 - $3.14 $99,833 - $144,458
-46,006 Reduced 38.51%
73,455 $189,000
Q2 2019

Aug 14, 2019
BUY
$2.53 - $3.04 $77,139 - $92,689
30,490 Added 34.27%
119,461 $358,000
Q1 2019

May 15, 2019
BUY
$2.51 - $3.73 $106,602 - $158,416
42,471 Added 91.34%
88,971 $264,000
Q4 2018

Feb 14, 2019
SELL
$1.59 - $2.66 $69,053 - $115,523
-43,430 Reduced 48.29%
46,500 $111,000
Q3 2018

Nov 14, 2018
BUY
$1.59 - $2.42 $26,409 - $40,196
16,610 Added 22.65%
89,930 $193,000
Q2 2018

Aug 14, 2018
SELL
$2.26 - $4.65 $1,435 - $2,952
-635 Reduced 0.86%
73,320 $166,000
Q1 2018

May 15, 2018
BUY
$3.51 - $6.04 $126,988 - $218,521
36,179 Added 95.77%
73,955 $348,000
Q4 2017

Feb 14, 2018
SELL
$3.26 - $4.78 $841 - $1,233
-258 Reduced 0.68%
37,776 $123,000
Q3 2017

Nov 14, 2017
BUY
$3.48 - $4.44 $132,358 - $168,870
38,034
38,034 $168,000

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email